Igor Bilinsky's Net Worth
$1.16 Million
Who is Igor Bilinsky?
Igor Bilinsky has an estimated net worth of $1.16 Million. This is based on reported shares across multiple companies, which include IOVANCE BIOTHERAPEUTICS, INC., Ignyta, Inc., Oncternal Therapeutics, Inc., AmpliPhi Biosciences Corp, and VICAL INC.
SEC CIK
Igor Bilinsky's CIK is 0001594604
Past Insider Trading and Trends
2024 was Igor Bilinsky's most active year for acquiring shares with 9 total transactions. Igor Bilinsky's most active month to acquire stocks was the month of December. 2024 was Igor Bilinsky's most active year for disposing of shares, totalling 14 transactions. Igor Bilinsky's most active month to dispose stocks was the month of December. 2014 saw Igor Bilinsky paying a total of $128,700.00 for 315,000 shares, this is the most they've acquired in one year. In 2024 Igor Bilinsky cashed out on 80,147 shares for a total of $329,454.91, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Snapshot price: $10.25
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.54% | 1.39K |
$9.77 | -$13,951.56 | 55.81K |
Oct 14
| |||
Form 4
| +32.28% | 13.28K |
$10.85 | -$148,373.75 | 54.42K |
Sep 3
| |||
Form 4
| +3.48% | 1.39K |
$8.68 | -$12,395.04 | 41.14K |
Jul 15
| |||
Form 4
| +4.55% | 1.73K |
$8.37 | -$14,932.08 | 39.76K |
Jun 3
| |||
Form 4
| +3.78% | 1.39K |
$11.89 | -$16,967.03 | 38.03K |
Apr 15
| |||
Form 4
| +22.68% | 6.77K |
$16.96 | -$123,587.52 | 36.64K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +4.32% | 1.24K |
$8.37 | -$13,199.49 | 29.87K |
Jan 16
| |||
Form 4
| +5.21% | 1.42K |
$3.57 | -$4,980.15 | 28.63K |
Oct 16
| |||
Form 4
| +5.50% | 1.42K |
$7.76 | -$10,825.20 | 27.21K |
Jul 14
| |||
Form 4
| +5.81% | 1.42K |
$5.64 | -$7,867.80 | 25.8K |
Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| +36.95% | 6.58K |
$6.43 | -$30,034.53 | 24.38K |
Jan 17
| |||
Form 4
| +87.30% | 8.3K |
$6.11 | -$64,478.83 | 17.8K |
Jan 3
| |||
Form 4
|
∞
| 9.5K |
$7.73 | -$72,244.58 | 9.5K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ignyta, Inc. No price found
GM, Immuno-Oncology/SVP Sp Ops
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 6.96K |
—
|
—
| 6.96K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oncternal Therapeutics, Inc. (ONCT) Snapshot price: $4.47
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AmpliPhi Biosciences Corp (ARMP) Snapshot price: $2.4
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VICAL INC (FRTX) Snapshot price: $0.95
Sr VP, Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.64% | -1.26K |
$0.70 | -$878.71 | 193.8K |
Scheduled
|
Jul 13
| ||
Form 4
| -0.64% | -1.26K |
$0.93 | -$1,172.78 | 195.06K |
Scheduled
|
Apr 13
| ||
Form 4
| +55.42% | 70K |
$0.01 | $700.00 | 196.31K |
Jan 19
| |||
Form 4
| -1.05% | -1.33K |
$1.16 | -$1,543.66 | 126.31K |
Scheduled
|
Jan 12
| ||
Form 4
| -1.04% | -1.33K |
$1.08 | -$1,445.54 | 127.65K |
Scheduled
|
Oct 13
| ||
Form 4
| -8.83% | -12.50K |
$1.25 | -$15,671.25 | 128.98K |
Scheduled
|
Aug 26
| ||
Form 4
| -0.93% | -1.33K |
$1.16 | -$1,553.54 | 141.48K |
Scheduled
|
Jul 11
| ||
Form 4
| -0.80% | -1.15K |
$1.21 | -$1,387.24 | 142.82K |
Scheduled
|
Apr 11
| ||
Form 4/A
| +166.77% | 90K |
$0.01 | $900.00 | 143.97K |
Jan 10
| |||
Form 4
| +158.51% | 88.28K |
$1.42 | $125,376.32 | 143.97K |
Jan 10 - Jan 13
| |||
Form 4
| -0.10% | -54.00 |
$1.31 | -$70.74 | 55.69K |
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||